Concepedia

Christopher Reading

CR

Statistics

Publications

14

Citations

1.9K

H-Index

14

Active since

1976

Affiliations

New Frontier(Current)

Département Santé Animale

Pfizer (United States)

Molecular Discovery (United Kingdom)

Christopher Reading is an author at New Frontier specializing in microbiology, life sciences, and beta-lactamase inhibitors.

Publications per year

1976–1997

14

Publications

14

Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from <i>Streptomyces clavuligerus</i>

Christopher Reading, Martin Cole · Antimicrobial Agents and Chemotherapy · 1977 · 724 citations · Full text

, , +17

Naturally-occurring .BETA.-lactamase inhibitors with antibacterial activity.

A. G. BROWN, Douglas Butterworth, Martin Cole et al. · The Journal of Antibiotics · 1976 · 395 citations · Full text

, , +13

Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography

M Foulstone, Christopher Reading · Antimicrobial Agents and Chemotherapy · 1982 · 199 citations

, , +15

Holomycin and an antibiotic(MM 19290) related to tunicamycin, metabolites of Streptomyces clavuligerus.

M. Kenig, Christopher Reading · The Journal of Antibiotics · 1979 · 104 citations · Full text

, , +4

New paraherquamide antibiotics with anthelmintic activity.

SIMON E. BLANCHFLOWER, R. M. BANKS, Jeremy R. Everett et al. · The Journal of Antibiotics · 1991 · 98 citations · Full text

, , +14

1–5 of 14